You are using an older browser version. Please use a supported version for the best MSN experience.

AstraZeneca hopes to trial 'blockbuster' products in 2023 that will make over a billion in revenue: CFO

Aradhana Sarin, AstraZeneca's chief financial officer, discusses the company's growth plans and its pipeline of products.
image beaconimage beaconimage beacon